Ascorbic acid and rates of cognitive decline in Alzheimer's disease

Gene Bowman, Hiroko Dodge, Balz Frei, Carlo Calabrese, Barry Oken, Jeffrey Kaye, Joseph Quinn

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The brain maintains high levels of ascorbic acid (AA) despite a concentration gradient favoring diffusion from brain to peripheral tissues. Dietary antioxidants, including AA, appear to modify the risk of Alzheimer's disease (AD). The objective of this study was to test the hypothesis that neurodegeneration in AD is modified by brain levels of AA. Thirty-two patients with mild to moderate AD participated in a biomarker study involving standardized clinical assessments over one year. Cerebrospinal fluid (CSF) and serum were collected at baseline for AA and albumin content. Cognitive measures were collected at baseline and one year. CSF and plasma AA failed to predict cognitive decline independently, however, CSF: plasma AA ratio did. After adding CSF Albumin Index (an established marker of blood-brain barrier integrity) to the regression models the effect of CSF: plasma AA ratio as a predictor of cognitive decline was weakened. CSF: plasma AA ratio predicts rate of decline in AD. This relationship may indicate that the CSF: plasma AA ratio is an index of AA availability to the brain or may be an artifact of a relationship between blood-brain barrier impairment and neurodegeneration.

Original languageEnglish (US)
Pages (from-to)93-98
Number of pages6
JournalJournal of Alzheimer's Disease
Volume16
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Ascorbic Acid
Alzheimer Disease
Cerebrospinal Fluid
Brain
Blood-Brain Barrier
Albumins
Cognitive Dysfunction
Artifacts
Antioxidants
Biomarkers
Serum

Keywords

  • Albumin
  • Alzheimer's disease
  • Antioxidants
  • Ascorbic acid
  • Blood-brain barrier
  • Cerebrospinal fluid
  • Cognitive decline
  • Vitamin C

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Ascorbic acid and rates of cognitive decline in Alzheimer's disease. / Bowman, Gene; Dodge, Hiroko; Frei, Balz; Calabrese, Carlo; Oken, Barry; Kaye, Jeffrey; Quinn, Joseph.

In: Journal of Alzheimer's Disease, Vol. 16, No. 1, 2009, p. 93-98.

Research output: Contribution to journalArticle

@article{ab400c409883475f9fbac606ed3161f7,
title = "Ascorbic acid and rates of cognitive decline in Alzheimer's disease",
abstract = "The brain maintains high levels of ascorbic acid (AA) despite a concentration gradient favoring diffusion from brain to peripheral tissues. Dietary antioxidants, including AA, appear to modify the risk of Alzheimer's disease (AD). The objective of this study was to test the hypothesis that neurodegeneration in AD is modified by brain levels of AA. Thirty-two patients with mild to moderate AD participated in a biomarker study involving standardized clinical assessments over one year. Cerebrospinal fluid (CSF) and serum were collected at baseline for AA and albumin content. Cognitive measures were collected at baseline and one year. CSF and plasma AA failed to predict cognitive decline independently, however, CSF: plasma AA ratio did. After adding CSF Albumin Index (an established marker of blood-brain barrier integrity) to the regression models the effect of CSF: plasma AA ratio as a predictor of cognitive decline was weakened. CSF: plasma AA ratio predicts rate of decline in AD. This relationship may indicate that the CSF: plasma AA ratio is an index of AA availability to the brain or may be an artifact of a relationship between blood-brain barrier impairment and neurodegeneration.",
keywords = "Albumin, Alzheimer's disease, Antioxidants, Ascorbic acid, Blood-brain barrier, Cerebrospinal fluid, Cognitive decline, Vitamin C",
author = "Gene Bowman and Hiroko Dodge and Balz Frei and Carlo Calabrese and Barry Oken and Jeffrey Kaye and Joseph Quinn",
year = "2009",
doi = "10.3233/JAD-2009-0923",
language = "English (US)",
volume = "16",
pages = "93--98",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Ascorbic acid and rates of cognitive decline in Alzheimer's disease

AU - Bowman, Gene

AU - Dodge, Hiroko

AU - Frei, Balz

AU - Calabrese, Carlo

AU - Oken, Barry

AU - Kaye, Jeffrey

AU - Quinn, Joseph

PY - 2009

Y1 - 2009

N2 - The brain maintains high levels of ascorbic acid (AA) despite a concentration gradient favoring diffusion from brain to peripheral tissues. Dietary antioxidants, including AA, appear to modify the risk of Alzheimer's disease (AD). The objective of this study was to test the hypothesis that neurodegeneration in AD is modified by brain levels of AA. Thirty-two patients with mild to moderate AD participated in a biomarker study involving standardized clinical assessments over one year. Cerebrospinal fluid (CSF) and serum were collected at baseline for AA and albumin content. Cognitive measures were collected at baseline and one year. CSF and plasma AA failed to predict cognitive decline independently, however, CSF: plasma AA ratio did. After adding CSF Albumin Index (an established marker of blood-brain barrier integrity) to the regression models the effect of CSF: plasma AA ratio as a predictor of cognitive decline was weakened. CSF: plasma AA ratio predicts rate of decline in AD. This relationship may indicate that the CSF: plasma AA ratio is an index of AA availability to the brain or may be an artifact of a relationship between blood-brain barrier impairment and neurodegeneration.

AB - The brain maintains high levels of ascorbic acid (AA) despite a concentration gradient favoring diffusion from brain to peripheral tissues. Dietary antioxidants, including AA, appear to modify the risk of Alzheimer's disease (AD). The objective of this study was to test the hypothesis that neurodegeneration in AD is modified by brain levels of AA. Thirty-two patients with mild to moderate AD participated in a biomarker study involving standardized clinical assessments over one year. Cerebrospinal fluid (CSF) and serum were collected at baseline for AA and albumin content. Cognitive measures were collected at baseline and one year. CSF and plasma AA failed to predict cognitive decline independently, however, CSF: plasma AA ratio did. After adding CSF Albumin Index (an established marker of blood-brain barrier integrity) to the regression models the effect of CSF: plasma AA ratio as a predictor of cognitive decline was weakened. CSF: plasma AA ratio predicts rate of decline in AD. This relationship may indicate that the CSF: plasma AA ratio is an index of AA availability to the brain or may be an artifact of a relationship between blood-brain barrier impairment and neurodegeneration.

KW - Albumin

KW - Alzheimer's disease

KW - Antioxidants

KW - Ascorbic acid

KW - Blood-brain barrier

KW - Cerebrospinal fluid

KW - Cognitive decline

KW - Vitamin C

UR - http://www.scopus.com/inward/record.url?scp=58849157247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849157247&partnerID=8YFLogxK

U2 - 10.3233/JAD-2009-0923

DO - 10.3233/JAD-2009-0923

M3 - Article

C2 - 19158425

AN - SCOPUS:58849157247

VL - 16

SP - 93

EP - 98

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -